KE / Domain	AOP entity (KE/KER)	Input (manipulation / sample)	Method / Assay (SOP notes)	Output / Measurement	Interpretation / Context fields to capture	Exemplar peer-reviewed manuscripts	Protocol / SOP notes (attach)	S&T considerations (ontology / mapping)
FoxJ1 expression and ciliated cell differentiation	KE: FoxJ1, decreased (Event 4); KER: FoxJ1 ↓ → Cilia #/length ↓; p73-FoxJ1 regulatory axis in multiciliogenesis	Primary human airway epithelial cells at ALI; mouse tracheal epithelial cells; p73 knockout models; siRNA knockdown experiments	FoxJ1 gene and protein expression analysis. qRT-PCR for FoxJ1 mRNA. Immunofluorescence or Western blot for FoxJ1 protein. Confocal microscopy for FoxJ1+ cell quantification. Co-staining with cilia markers (acetylated α-tubulin). ChIP-seq or luciferase assays for p73-FoxJ1 transcriptional regulation.	FoxJ1 mRNA levels (fold change); FoxJ1 protein levels; Percentage of FoxJ1+ cells; Co-localization of FoxJ1 with ciliated cell markers; p73 binding to FoxJ1 promoter; Correlation between FoxJ1 and cilia number/length	Cell type and species; culture conditions; days at ALI; p73 genotype or knockdown efficiency; qRT-PCR primers and normalization genes; antibodies for immunofluorescence/Western blot; imaging parameters; cell counting methodology; ChIP-seq conditions; replicate number	Marshall et al. (2016). p73 is required for multiciliogenesis and regulates the Foxj1-associated gene network. Cell Reports. 14(10):2289-300.	Include cell culture and ALI differentiation protocol, p73 manipulation methods (knockout, siRNA), qRT-PCR protocol, immunofluorescence staining and imaging, FoxJ1+ cell quantification, ChIP or promoter assay details, correlation analysis with cilia endpoints	Biolink: MeasurementProcess; OBI: qRT-PCR assay, immunofluorescence assay, ChIP-seq; Mapping: KE FoxJ1 decrease (Event 4), KER FoxJ1 → cilia; Pathway: p73-FoxJ1 transcriptional network; Gene: FOXJ1
FoxJ1 expression in airway epithelium (toxicology endpoint)	KE: FoxJ1, decreased (Event 4); assessment of ciliated cell population in response to environmental exposures	MucilAir™ 3D human bronchial epithelial model at ALI; repeated exposure to heated tobacco aerosol or cigarette smoke (28 days)	Immunohistochemistry for FoxJ1 in differentiated airway epithelium. Tissue sections stained with anti-FoxJ1 antibody. Confocal or brightfield microscopy imaging. Quantification of FoxJ1+ cell percentage or intensity. Histological assessment of tissue architecture.	Percentage of FoxJ1+ cells; FoxJ1 staining intensity; Changes in ciliated cell population over exposure period; Correlation with functional endpoints (cilia beat frequency)	Cell model (MucilAir™); donor information; days at ALI; exposure regimen (dose, duration, frequency); fixation and staining protocols; antibody specifics; imaging parameters; quantification method (cell counting, intensity measurement); replicate number; baseline comparison	Chapman et al. (2023). Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke. Toxicol Rep.	Document tissue fixation and processing, immunohistochemistry protocol, antibody validation, imaging acquisition settings, FoxJ1+ cell quantification method, quality control for staining consistency, correlation with functional assays	Biolink: MeasurementProcess; OBI: immunohistochemistry assay; Mapping: KE FoxJ1 decrease; ENVO: environmental exposure context; Toxicological assessment; Correlation with cilia function
FoxJ1 expression in multi-endpoint toxicology assessment	KE: FoxJ1, decreased (Event 4); part of comprehensive airway epithelium assessment	MucilAir™ 3D airway epithelium at ALI; repeated exposure to e-cigarette aerosol or cigarette smoke	Immunohistochemical analysis of FoxJ1 expression. Quantification of ciliated cell marker (FoxJ1) alongside goblet cell markers (Muc5AC) to assess epithelial cell balance. Multi-endpoint assessment including morphology, function, and molecular markers.	FoxJ1+ cell percentage; FoxJ1 staining pattern; Ratio of ciliated cells (FoxJ1+) to goblet cells (Muc5AC+); Integration with functional ciliary endpoints	3D culture model type; exposure conditions; immunostaining protocol; imaging approach; cell type quantification method; co-staining strategy; replicate number; comparison across exposure types and doses	Czekala et al. (2021). Multi-endpoint analysis of human 3D airway epithelium following repeated exposure to whole electronic vapor product aerosol or cigarette smoke.	Include detailed immunostaining protocol, dual-staining approach for cell type balance, imaging and analysis workflow, integration of morphological and functional data, quality metrics	Biolink: MeasurementProcess; OBI: immunohistochemistry; Mapping: KE FoxJ1 decrease; Multi-endpoint integration; Cell type balance assessment; Toxicology context
FoxJ1 and ciliated cell gene expression (transcriptomics)	KE: FoxJ1, decreased (Event 4); transcriptomic assessment of ciliated cell differentiation program	3D organotypic human airway epithelial cultures; exposure to e-cigarette aerosol vs cigarette smoke; RNA-seq analysis	RNA-seq for genome-wide gene expression profiling. Differential expression analysis for FoxJ1 and ciliated cell-associated genes. Gene set enrichment analysis (GSEA) for ciliogenesis pathways. Validation by qRT-PCR for key genes. Correlation of gene expression changes with functional phenotypes.	FoxJ1 gene expression (log2 fold change); Differential expression of ciliated cell gene network; Enrichment scores for ciliogenesis pathways; Validation of key targets by qRT-PCR; Integration with protein and functional data	Culture model; passage number; exposure conditions; RNA extraction method; sequencing platform and depth; bioinformatics pipeline version; differential expression thresholds; pathway databases used; qRT-PCR validation genes; normalization approach; batch correction	Haswell et al. (2017). Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics.	Document RNA extraction and QC, library preparation, sequencing parameters, bioinformatics workflow (alignment, quantification, differential expression, pathway analysis), qRT-PCR validation protocol, data integration approach	Biolink: MeasurementProcess; OBI: RNA-seq assay, qRT-PCR; Mapping: KE FoxJ1 decrease, ciliated cell gene network; Transcriptomics; Gene: FOXJ1 and ciliated cell transcriptional program; Systems-level assessment
